Acurx Pharmaceuticals News

Acurx Pharmaceuticals | 8-K: Current report

Nov 13 07:08 ET

Acurx Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 12 16:46 ET

Acurx Pharmaceuticals | 8-K: Current report

Aug 9 07:17 ET

Acurx Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 8 16:53 ET

Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Sailer Carl

Jun 18 16:20 ET

Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Scodari Joseph C

Jun 18 16:19 ET

Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director HARRISON THOMAS L

Jun 18 16:18 ET

Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Donohue James J.

Jun 18 16:17 ET

Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DEAN JACK H

Jun 18 16:16 ET

Acurx Pharmaceuticals | 8-K: Current report

Jun 17 16:18 ET

Acurx Pharmaceuticals | 8-K: Current report

May 15 07:15 ET

Acurx Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

May 14 16:43 ET

Acurx Pharmaceuticals | ARS: Annual Report to Security Holders

Apr 29 16:19 ET

Acurx Pharmaceuticals | DEFA14A: Others

Apr 29 16:18 ET

Acurx Pharmaceuticals | DEF 14A: Definitive information statements

Apr 29 16:13 ET

Acurx Pharmaceuticals | RW: Registration Withdrawal Request

Apr 17 16:10 ET

Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer LUCI DAVID P

Apr 3 21:59 ET

Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Shawah Robert G.

Apr 3 21:59 ET

Acurx Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director DELUCCIA ROBERT J

Apr 3 21:59 ET

Acurx Pharmaceuticals | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Apr 2 07:34 ET